![N-[(5E)-2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene]methanamine hydrobromide (1:1)](https://static.cymitquimica.com/cas-image/395068-n-5e-23-diphenyl-124-thiadiazol-5-2h-ylidene-methanamine-hydrobromide-1-1.png)
CAS: 70375-43-8 - N-[(5E)-2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene]methanamine hydrobromide (1:1)
Formula:C15H14BrN3S
InChI:InChI=1/C15H13N3S.BrH/c1-16-15-17-14(12-8-4-2-5-9-12)18(19-15)13-10-6-3-7-11-13;/h2-11H,1H3;1H/b16-15+;
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SCH-202676 REF: TR-S200038CAS: 70375-43-8 | - - - | 5,339.00 € | Tue 07 Jan 25 |
 | SCH-202676 REF: 3D-VCA37543CAS: 70375-43-8 | Min. 95% | To inquire | Tue 07 Jan 25 |
 | SCH-202676 HBr REF: TM-T24770CAS: 70375-43-8 | 98% | 1,386.00 €~2,320.00 € | Tue 14 Jan 25 |
| SCH-202676 Hydrobromide REF: TR-S199935CAS: | - - - | - - - | Discontinued product |
SCH-202676
Controlled ProductCAS:70375-43-8
Formula:
C15H13N3S
Color and Shape:
Neat
Molecular weight:
267.349
Ref: TR-S200038
| 500mg | 5,339.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
SCH-202676
CAS:70375-43-8
SCH-202676 is a small molecule that exhibits inhibitory properties against the epidermal growth receptor (EGFR) …
Formula:
C15H14BrN3S
Purity:
Min. 95%
Molecular weight:
348.3 g/mol
Ref: 3D-VCA37543
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
SCH-202676 HBr
CAS:70375-43-8
SCH-202676 HBr is an allosteric agonist. It also an GPCR antagonist.
Formula:
C15H13N3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
267.35
Ref: TM-T24770
| 25mg | 1,386.00 € | ||
| 50mg | 1,838.00 € | ||
| 100mg | 2,320.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
SCH-202676 Hydrobromide
Applications SCH-202676 Hydrobromide acts as a reversible inhibitor with agonist and antagonist binding to G-protein-coupled …
Formula:
C15H14BrN3S
Color and Shape:
White to Pale Beige Solid
Molecular weight:
348.261
Ref: TR-S199935
| 5mg | Discontinued | Request information |
